The use of a side effect as a qualitative indicator of plasma chlorpromazine levels
- 26 January 1999
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 9 (1-2) , 77-82
- https://doi.org/10.1016/s0924-977x(98)00005-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Response in chronic schizophrenia correlated with chlorpromazine, 7-OH-chlorpromazine and chlorpromazine sulfoxide levelsEuropean Neuropsychopharmacology, 1996
- Effect of Storage on the Plasma Concentration of Chlorpromazine and Six of Its MetabolitesTherapeutic Drug Monitoring, 1991
- Formation of Active Metabolites of Psychotropic DrugsClinical Pharmacokinetics, 1990
- Plasma Levels of Chlorpromazine in SchizophreniaArchives of General Psychiatry, 1978
- 3H-haloperidol binding to dopamine receptors in rat corpus striatum: Influence of chlorpromazine metabolites and derivativesEuropean Journal of Pharmacology, 1978
- Plasma Level Monitoring of Antipsychotic DrugsClinical Pharmacokinetics, 1978
- Correlation Between Plasma Chlorpromazine and its Metabolites and Clinical Ratings in Patients with Acute Relapse of Schizophrenic and Paranoid PsychosisThe British Journal of Psychiatry, 1977
- Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levelsAmerican Journal of Psychiatry, 1976
- THE RELATIONSHIP OF PLASMA CHLORPROMAZINE TO ITS 7‐HYDROXY AND SULPHOXIDE METABOLITES IN A LARGE POPULATION OF CHRONIC SCHIZOPHRENICSBritish Journal of Clinical Pharmacology, 1974
- Effects of mode of management on plasma chlorpromazine in psychiatric patientsClinical Pharmacology & Therapeutics, 1973